F3 and antiphospholipid syndrome: Notably, two of these patients were diagnosed with triple-positive antiphospholipid syndrome (APS), highlighting the importance of identifying APS patients, as interactions between antiphospholipid antibodies and thromboplastin used in point-of-care (POC) INR testing may influence results [30].